enVVeno Medical (NASDAQ:NVNO) Releases Earnings Results, Misses Expectations By $0.02 EPS

by · The Markets Daily

enVVeno Medical (NASDAQ:NVNO – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.35) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.02), Zacks reports.

enVVeno Medical Price Performance

NASDAQ:NVNO traded down $0.02 during trading hours on Friday, hitting $3.35. The stock had a trading volume of 75,755 shares, compared to its average volume of 103,098. The company has a 50 day simple moving average of $4.18 and a two-hundred day simple moving average of $4.81. The firm has a market capitalization of $44.66 million, a price-to-earnings ratio of -2.60 and a beta of 1.21. enVVeno Medical has a one year low of $3.01 and a one year high of $6.97.

enVVeno Medical Company Profile

(Get Free Report)

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Recommended Stories